Clinical Trial Update: An Open-Label Study Of Lamictal In Neurotic Excoriation [Phase 2]

View source ↗

Summary

An open-label Phase 2 study evaluating lamotrigine (Lamictal) for neurotic excoriation, with neurotic disorders and obsessive-compulsive disorder as conditions;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotic Disorders
• Neurotic Excoriation
• Obsessive-compulsive Disorder

Drugs mentioned

• LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: University of Minnesota | Conditions: Neurotic Disorders, Obsessive-Compulsive Disorder | Phase 2 | Status: COMPLETED